Results 111 to 120 of about 4,732 (200)

The flavonoid isoliquiritigenin promotes lifespan extension of Caenorhabditis elegans through the transcription factor DAF-16 and aquaporin-2. [PDF]

Braz J Med Biol Res
Zhao X, Ren L, Gu D, Yao Y, Wang S, Gao J, Qi Y.   +6 more
europepmc   +1 more source

Unveiling the Therapeutic Potential of Isoliquiritigenin in Prostate Cancer: Insights from a Systematic Review and Meta-Analysis

Background: Prostate cancer is a significant and primary cause of cancer-related mortality among men worldwide with treatment challenges that include resistance to conventional therapies.
Roshini , M, Dhanshika , V, Dhivya, K, Manisha, S, Ragavarshini , D   +4 more
core   +1 more source

Isoliquiritigenin Impedes Breast Cancer Progression through PITX1-PFKP-Mediated Glycolysis Reprogramming. [PDF]

Oncol Res
Liu C, Zhang Z, Feng R, Zeng M, Li H, Zhu M, Zhuang L, Li Z, Wu T.   +8 more
europepmc   +1 more source

Isoliquiritigenin represses the pro-fibrotic TGF-β/smad2 signaling and nuclear enriched abundant transcript 1 (NEAT1) in oral submucous fibrosis. [PDF]

J Dent Sci
Tseng CS, Wang SM, Liao YW, Huang HH, Yu CC, Chen Y.   +5 more
europepmc   +1 more source

The cocrystals of isorhamnetin and isoliquiritigenin with 4,4'-bipyridine: system characterization, stability, dissolution and anticancer activity. [PDF]

RSC Adv
Liu Y, Lei J, Li T, Zhong A, Zhu Z, Lu J, Wang Z, Zhao P, Wu Z.   +8 more
europepmc   +1 more source

Exploring the Active Components of Buqi-Zhitong-Decoction and Its Therapeutic Potential for Chronic Fatigue Syndrome Based on LC-MS/MS and Network Pharmacology. [PDF]

J Sep Sci
Liu Y, Xin Y, Wang X, Wen L, Guo L, He W, Li Q.   +6 more
europepmc   +1 more source

Isoliquiritigenin alleviates ulcerative colitis by enhancing the intestinal barrier and improving intestinal microbiota via inhibiting the TLR4/MyD88/NF-κB pathway. [PDF]

Sci Rep
Li R, Sun Y, Feng M, Kelsang D, Cai H, Zhang J.   +5 more
europepmc   +1 more source

Isoliquiritigenin Suppresses Oral Squamous Cell Carcinoma Progression by Targeting FABP5-Mediated Lipid Metabolism: Association with the circPOLB/miR-548ae-3p/C-MYC Axis. [PDF]

Oncol Res
Li L, Deng H, Li Z, Li Y, Liu L, Xie L, Chen Y.   +6 more
europepmc   +1 more source

The effect of isoliquiritigenin on the hERG potassium channel

, 2020
Mujahid, M, Wang, T, Ellory, C, Wilkins, R, Ma, Y-L   +4 more
openaire   +1 more source

Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications. [PDF]

Front Pharmacol
Ding M, Guo F, Lin P.
europepmc   +1 more source